Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on June 13, 2016. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Vaccine Analysis

Closed
2016-Q-65300Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

Contract Value

$71,082

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Michael A. HarwellContracting Officer

Full Description

Show more
The Centers for Disease Control and Prevention, NCIRD/ISD, 1600 Clifton Rd. NE, Mailstop A19, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract to The Regents of The University of Colorado 10331 E 17th Place F428 Aurora, Colorado to collect and analyze 600 herpes zoster vaccine samples from the Centers for Disease Control and Prevention. NAICS Code: 541711 Period of Performance: 07/01/2016 to 05/31/2017 The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 13.106-1(b)(1)(i). The University of Colorado is part of an ongoing collaboration with the Centers for Disease Control and Prevention in researching the Herpes Zoster vaccines of both Merck and GSK. Market research has provided no other company/institution that could identify the necessary donors, collect the needed amount of serum, and process the samples in time to complete the project by 05/31/2017. Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency for future procurement. Please forward the capability statement and/or pricing information to Michael Harwell, Contracting Specialist, Reference 200-2013-M-54126, Centers for Disease Control, Procurement and Grants Office, ATTN: Michael Harwell, MS: K14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov. This is a posting of a sole source award to The Regents of The University of Colorado and is not a request for competition.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS